Montelukast Levocetirizine Tablets – A Combination Formulation for Allergy Management
Businesses / Posted 3 days ago by Unimarck Pharma / 8 views / New
Allergies can affect everyday comfort, sleep quality, and daily activities. Sneezing, a runny nose, nasal congestion, itchy eyes, and other allergic symptoms can make routine tasks challenging. Montelukast Levocetirizine Tablets combine two active pharmaceutical ingredients that work through different mechanisms to support the management of allergic conditions.
Unimarck Pharma focuses on pharmaceutical formulations that address different therapeutic requirements. Its Montelukast Levocetirizine Tablets page highlights a combination of Montelukast 10 mg and Levocetirizine 5 mg, developed for allergy-related therapeutic applications.
What Are Montelukast Levocetirizine Tablets?
Montelukast Levocetirizine Tablets contain two active ingredients: Montelukast and Levocetirizine. Both ingredients work differently to manage allergic responses.
Levocetirizine is an antihistamine that helps reduce the effects of histamine, a chemical responsible for symptoms such as sneezing, itching, watery eyes, and a runny nose.
Montelukast belongs to a class of medicines known as leukotriene receptor antagonists. It works by blocking leukotrienes, substances involved in allergic inflammation and certain respiratory symptoms.
The combination brings these two mechanisms together in one tablet, providing a convenient formulation when prescribed by a qualified healthcare professional.
Key Features of Montelukast and Levocetirizine Combination
The combination of these ingredients offers several important formulation characteristics:
1. Dual-Ingredient Formulation
The combination brings together an antihistamine and a leukotriene receptor antagonist to address different pathways involved in allergic responses.
2. Support for Allergic Rhinitis Management
Levocetirizine helps manage common symptoms associated with allergic rhinitis, including sneezing, nasal irritation, and watery eyes.
3. Complementary Mechanisms of Action
Montelukast and Levocetirizine act through different biological pathways, making their combination relevant to specific allergy-management requirements.
4. Convenient Tablet Formulation
Combining both active ingredients into a single dosage form can simplify administration when the combination is prescribed.
Understanding the Formulation Strength
Unimarck Pharma’s product information highlights the following composition:
- Montelukast: 10 mg
- Levocetirizine: 5 mg
The formulation combines two established pharmaceutical ingredients in a single tablet. The appropriate dose and duration of treatment must always be determined by a healthcare professional based on the patient’s condition and medical history.
- Listing ID: 118689